ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation?

C. Bryan, V. Chadha, B. Warady.

Midwest Transplant Network, Kansas City, KS
Nephrology, Childrens Mercy Hospital, Kansas City, MO
Nephrology, Childrens Mercy Hospital, Kansas City, MO.

Meeting: 2016 American Transplant Congress

Abstract number: D151

Keywords: Allocation, Epitopes, HLA antibodies, Pediatric

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Kidney-Pediatrics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Epitope Matching Outperforms Traditional Antigen Matching as a Predictor of De Novo Donor Specific Antibody Development after Renal Transplantation
  • HLA Broad Antigen and Eplet Mismatches in Determining the Risk of Acute Rejection After Kidney Transplantation

Introduction. It is now appreciated that greater HLA DR mismatching of the first pediatric kidney transplantation is associated with higher degrees of sensitization, lower rates of retransplantation, longer time to retransplantation and worse graft outcomes in those who are subsequently retransplanted (Transplantation 2013; 95:1218). In view of those and other data our pediatric renal transplant program has preferentially used only 0 and 1 HLA DR mismatched kidneys, while consideration for 2 DR mismatched kidneys is reserved for patients whose sensitization levels and/or course on dialysis mandates an imminent need for a kidney. An appealing new paradigm is an HLA DR and DQ epitope matching strategy that can ideally minimize de novo donor specific antibody (dnDSA) production to DR and DQ antigens when < 10 DR and < 17 DQ eplet mismatches are present in the donor (AJT 2013; 13:3114). We evaluated the role of DR and DQ eplet mismatching of deceased donor (dd) offers made to our pediatric wait list candidates.

Methods. We evaluated 79 offers that were made to 16 children on our UNOS waiting list from 27 consecutive dd from 4/14/14 to 3/23/15. Each donor/candidate pair was HLA DR (ß1, ß3 and/or ß5) and DQ (α1 & ß1) allele typed by rSSO and were then evaluated by the HLA matchmaker program for eplet mismatches.

Results. The data in Table 1 show that 90.5% (19/21) of the 1 DR mismatched dd offers were above both the DR and DQ eplet thresholds making those candidates at high risk for dnDSA production. Furthermore, for 2 DR mismatched offers, 96.7% (56/58) of the candidates' offers had both a DR and DQ eplet threshold levels above 10 and 17, respectively.

 DR & DQ eplet thresholds  1 DR mismatched offers (n=21)  2 DR mismatched offers (n=58)
        <10  &  <17                 9.5% (2/21)                    3.4% (2/58)
        ≥10  &  ≥17                90.5% (19/21)                   96.6% (56/58)

Conclusions. Compared to DR matching, eplet mismatching more accurately defines the molecular difference between a donor and candidate but the fact that less than 10% of the offers existed where both the DR and DQ eplet threshold was in the low risk threshold may preclude strategies designed to optimize matching and access to dd organs.

CITATION INFORMATION: Bryan C, Chadha V, Warady B. Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation? Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bryan C, Chadha V, Warady B. Should HLA DR and DQ Eplet Mismatching Replace Traditional DR and DQ Mismatching for Deceased Donor Offers in Pediatric Renal Transplantation? [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/should-hla-dr-and-dq-eplet-mismatching-replace-traditional-dr-and-dq-mismatching-for-deceased-donor-offers-in-pediatric-renal-transplantation/. Accessed March 4, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.